| MicuRx discovers and develops novel antibiotics to combat drug-resistant
bacterial infections. Positioned to capture the benefits of research
and development expertise in the U.S. together with the high quality,
low cost discovery, preclinical and development infrastructure available
in China, the company has built a pipeline of discovery and development
programs for the treatment of Gram-positive bacteria, Gram-negative
bacteria and fungal infections. The company has research and development
facilities outside San Francisco, CA and in Shanghai.
Link to MicuRx China
|
|
